Cáncer Cabeza y Cuello
Plataforma Ensayos Clínicos
EVENTOS Y FORMACIÓN

TTCC-GrupoTratamiento Tumores Cabeza y CuelloFollow

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello - Spanish Head and Neck Cancer Cooperative Group- 2001

Avatar
Retweet on TwitterTTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted
AvatarMake Sense Campaign@MakeSenseCmpn·
09/22/21

Today, we're placing the spotlight on the importance of early diagnosis of head and neck cancer. Symptoms are easy to identify early, yet ... 60% of patients present with locally advanced disease at diagnosis.

Help us change this; #StayHNCAware https://bit.ly/2mZISfE

Reply on Twitter 1440571570834059264Retweet on Twitter 14405715708340592643Like on Twitter 14405715708340592645Twitter 1440571570834059264
AvatarTTCC-GrupoTratamiento Tumores Cabeza y Cuello@ttccgroup·
09/22/21

Role of Geriatric Assessment in Personalizing Therapy for Elderly Patients With Head and Neck Cancer - The ASCO Post ... https://ascopost.com/news/september-2021/role-of-geriatric-assessment-in-personalizing-therapy-for-elderly-patients-with-head-and-neck-cancer/?utm_source=TAP-EN-092121-INTL&utm_medium=email&utm_term=58ee1db3e7072e14254050ffec723f09#.YUrj7DQ75QM.twitter

Reply on Twitter 1440588256559570952Retweet on Twitter 1440588256559570952Like on Twitter 14405882565595709523Twitter 1440588256559570952
AvatarTTCC-GrupoTratamiento Tumores Cabeza y Cuello@ttccgroup·
09/21/21

FDA Grants Fast Track Designation to Ficlatuzumab for Relapsed or Recurrent Head and Neck Cancer ... https://www.cancernetwork.com/view/fda-grants-fast-track-designation-to-ficlatuzumab-for-relapsed-or-recurrent-head-and-neck-cancer a través de @CancerNetwrk

Reply on Twitter 1440352553921757184Retweet on Twitter 14403525539217571844Like on Twitter 14403525539217571847Twitter 1440352553921757184
Newsletter

TTCC-GrupoTratamiento Tumores Cabeza y CuelloFollow

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello - Spanish Head and Neck Cancer Cooperative Group- 2001

Avatar
Retweet on TwitterTTCC-GrupoTratamiento Tumores Cabeza y Cuello Retweeted
AvatarMake Sense Campaign@MakeSenseCmpn·
09/22/21

Today, we're placing the spotlight on the importance of early diagnosis of head and neck cancer. Symptoms are easy to identify early, yet ... 60% of patients present with locally advanced disease at diagnosis.

Help us change this; #StayHNCAware https://bit.ly/2mZISfE

Reply on Twitter 1440571570834059264Retweet on Twitter 14405715708340592643Like on Twitter 14405715708340592645Twitter 1440571570834059264
AvatarTTCC-GrupoTratamiento Tumores Cabeza y Cuello@ttccgroup·
09/22/21

Role of Geriatric Assessment in Personalizing Therapy for Elderly Patients With Head and Neck Cancer - The ASCO Post ... https://ascopost.com/news/september-2021/role-of-geriatric-assessment-in-personalizing-therapy-for-elderly-patients-with-head-and-neck-cancer/?utm_source=TAP-EN-092121-INTL&utm_medium=email&utm_term=58ee1db3e7072e14254050ffec723f09#.YUrj7DQ75QM.twitter

Reply on Twitter 1440588256559570952Retweet on Twitter 1440588256559570952Like on Twitter 14405882565595709523Twitter 1440588256559570952
AvatarTTCC-GrupoTratamiento Tumores Cabeza y Cuello@ttccgroup·
09/21/21

FDA Grants Fast Track Designation to Ficlatuzumab for Relapsed or Recurrent Head and Neck Cancer ... https://www.cancernetwork.com/view/fda-grants-fast-track-designation-to-ficlatuzumab-for-relapsed-or-recurrent-head-and-neck-cancer a través de @CancerNetwrk

Reply on Twitter 1440352553921757184Retweet on Twitter 14403525539217571844Like on Twitter 14403525539217571847Twitter 1440352553921757184
Newsletter
TTCC en cifras
0
Año de Creación
0
Número de Socios
0
Hospitales
Hazte Socio
Entidades Colaboradoras

WEB en renovación gracias a la colaboración de Bayer